Skip to content

S. 832 · 119th Congress (2025–2027)

EPIC Act of 2025

This bill lengthens the amount of time for which drug products must have market approval in order for the products to qualify for negotiation under the Medicare Drug Price Negotiation Program.

The Medicare Drug Price Negotiation Program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation.

The bill modifies these provisions so as to require drug products to also have had at least 11 years of market approval in order to qualify for negotiation beginning in 2028.

Show official title

A bill to amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is S. 832’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

Sponsor
Sen. Thomas Tillis (R-NC)
Cosponsors
7 cosponsors

4 original · 3 later

7 R

  1. Sen. Marsha Blackburn (R-TN)· Original · Mar 4, 2025
  2. Sen. Ted Budd (R-NC)· Original · Mar 4, 2025
  3. Sen. Steve Daines (R-MT)· Original · Mar 4, 2025
  4. Sen. James Lankford (R-OK)· Original · Mar 4, 2025
  5. Sen. John R. Curtis (R-UT)· Later · Apr 10, 2025
  6. Sen. Jim Banks (R-IN)· Later · Apr 29, 2025
  7. Sen. Roger Marshall (R-KS)· Later · Apr 29, 2025
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest

    Referred to committee

    Read twice and referred to the Committee on Finance.

    Sources

Committees

  1. SenateFinanceReferred Mar 4, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Titles (3)
  1. EPIC Act of 2025

    Display title, Short title · Introduced in Senate

  2. Ensuring Pathways to Innovative Cures Act of 2025

    Short title · Introduced in Senate

  3. A bill to amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

    Official title · Introduced in Senate